PRPaulo Ruiz-Grosso

Paulo Ruiz-Grosso

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Paulo Ruiz-Grosso has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Longitudinal changes in dose-normalized psychotropic medication exposure around transfer to a specialized older adult mental health service: a retrospective longitudinal study in Peru

    by Paulo Ruiz-Grosso, Luis Macedo-Orrego, Sonia Zevallos-Bustamante

    Objectives: This research aimed to characterize longitudinal changes in dose-normalized psychotropic exposure around transfer to a specialized older adult mental health service in Peru, with the primary contrast comparing the last eligible pre-transfer consultation (T0) with six months after transfer. We additionally explored characteristics associated with average medication-score levels and potential modification of the T0-to-6-month change. Methods: A retrospective longitudinal single-cohort study was conducted using routine clinical records from the Instituto Nacional de Salud Mental Honorio Delgado-Hideyo Noguchi in Lima, Peru. The primary analytic cohort comprised patients transferred to the older adult service who had valid longitudinal medication data at or before transfer and after transfer. A dose-normalized psychotropic medication score was calculated at approximately -6 months, -3 months, T0 (the last eligible consultation before transfer), +3 months, and +6 months. Longitudinal change was estimated using linear mixed-effects models with categorical time and participant-specific random intercepts; the prespecified primary contrast compared +6 months with T0. Sensitivity analyses evaluated alternative score definitions, age restrictions, influential observations, and participant-level cluster bootstrap resampling. Results: The primary analytic cohort included 213 participants; mean age at T0 was 65.5 years (SD 7.2), 59.2% were female, and the most frequent diagnostic categories were psychotic disorders (52.1%) and depressive disorders (29.1%). The medication score was 17.87 points higher at +6 months than at T0 (95% CI 12.18 to 23.57; p < 0.001), and the exploratory adjusted estimate was similar (17.82 points; 95% CI 12.10 to 23.54; p < 0.001). The primary contrast remained positive across alternative score definitions, age-restricted analyses, influence analyses, and participant-level bootstrap resampling. In exploratory effect-modification analyses, each 10-year increase in age was associated with a 10.94-point greater T0-to-+6-month change (95% CI 2.33 to 19.55; p = 0.013), although this association did not remain statistically significant after false-discovery-rate correction (FDR-adjusted p = 0.091); no other tested modifier showed evidence of interaction after FDR correction. Conclusions: Dose-normalized prescribed psychotropic exposure increased from a relative pre-transfer low point at T0 to 6 months after transfer, with similar estimates across sensitivity analyses. In the absence of a contemporaneous comparison group, this finding should be interpreted as a temporal association around service transfer rather than evidence that transfer itself caused the increase or that the resulting prescribing was clinically beneficial, harmful, or inappropriate.

  • Open Access

    Virtual and In-Person Psychiatric Care: Appointment Completion and Capacity Use in a Public Mental Health Service in Peru

    by Paulo Ruiz-Grosso, Luis Macedo-Orrego, Diego Rodriguez-Vargas, Maria Rivera-Encinas, Alejandra Arosemena, Maria Carazas-Vera, Abel Sagastegui, Sonia Zevallos-Bustamante

    Objective: To compare appointment completion and offered-slot utilization between virtual and in-person outpatient psychiatric care in Peru. Methods: We conducted a retrospective ecological longitudinal study using routinely collected monthly aggregate administrative indicators from January 2022 through June 2026, with modality-month as the unit. Virtual-minus-in-person differences and 95% confidence intervals used Newey-West standard errors with 12 lags. June 2026 was partial; slot utilization was restricted to 2024-2026. Results: Across 54 paired months, mean completion was 90.9% (SD=3.9) for virtual and 83.8% (SD=2.7) for in-person care; difference +7.2 points (95% CI=4.4-9.9). Across 30 paired months, slot utilization was 73.0% (SD=8.3) and 90.5% (SD=3.8), respectively; difference −17.5 points (95% CI=−24.5 to −10.4). Sensitivity analyses were similar. Conclusions: Virtual care had higher completion but lower slot utilization. Attendance and capacity use should be evaluated separately when planning hybrid psychiatric services. Outpatient psychiatric services increasingly operate as hybrid systems in which virtual and in-person visits coexist.

  • Open Access

    Mental health contact gaps among adults in Peru: a cross-sectional analysis of a nationally representative survey

    by Paulo Ruiz-Grosso, Luis Enrique Macedo Orrego, María Teresa Rivera Encinas, María Soledad Carazas Vera, Diego Mauricio Rodríguez Vargas, Alejandra Arosemena Aliaga, Abel Ampelio Sagástegui Soto, Sonia Zevallos Bustamante

    Objective: To estimate lifetime and 12-month mental health contact gaps among Peruvian adults with survey-defined mental disorders, and to describe inequalities in contact, perceived need for care, and mental health service use. Methods: We analyzed the information for adults of the 2022 Peruvian National Mental Health Survey, a cross-sectional household survey. The primary outcome was the survey-weighted proportion of adults with a 12-month mental disorder who reported no contact with an included source of mental health-related care during that period; the lifetime contact gap was descriptive. Perceived need was assessed using two derived 12-month perceived-need measures based on direct ENSM variables and service-contact routing items. Analyses incorporated weights, strata, and clusters. Adjusted prevalence ratios were estimated using survey-weighted Poisson models. Results: The dataset contained information on 13,840 individuals; 13,833 had complete survey-design information. Contact-gap denominators were 3,927 for lifetime disorders and 1,649 for 12-month disorders. The lifetime and 12-month contact gaps were 61.0% (95% CI 58.4–63.7) and 84.5% (95% CI 81.5–87.6), respectively. Rural estimates exceeded urban estimates in both periods; after adjustment, poverty and rural residence were associated with the lifetime gap, and extreme poverty with the 12-month gap. Among individuals meeting survey-based criteria for one or more 12-month mental disorders, 37.3% (95% CI 33.4–41.4) reported self-perceived need, whereas 25.6% (95% CI 21.8–29.8) reported that need had been identified by others. Annual psychological and psychiatric service use was 3.7% and 1.1%, respectively. Conclusions: Mental health contact gaps were high, particularly for one or more 12-month mental disorders, and were associated with social and territorial variables. These contact measures do not establish adequate, continuous, or effective treatment; which need to be addressed to understand the impact of the Peruvian mental health reform.

  • Open Access

    Prevalence and associated variables to alcohol abuse in public transportation drivers in Lima, Peru

    by Paulo Ruiz-Grosso, Jorge Osada

    Objective: To analyze the association of sociodemographic, occupational, and mental health variables with alcohol use disorders (AUD) among public transportation drivers in Lima, Peru. Materials and methods: A secondary analysis of a cross-sectional survey was conducted with data from 278 bus drivers (BD) and 227 mototaxi drivers (MTD) from 25 transportation companies selected through snowball sampling. AUD was assessed using the CAGE questionnaire (cutoffs ≥1 and ≥2 for AUD-1 and AUD-2, respectively). Sociodemographic, occupational, and mental health variables, including depression, anxiety, and burnout, were also recorded. Prevalence and associated factors were analyzed using logistic regression models. Results: Prevalence rates for AUD-1 and AUD-2 were 74.4% and 58.4%, respectively. Significant variation was observed between BD companies (p = 0.001), but not between BD and MTD. For AUD-1, male gender (OR = 7.8; 95%CI: 1.8-34.1), being a BD (OR = 0.27; 95%CI: 0.13-0.56), and being divorced (OR = 9.5; 95%CI: 1.14-79.03) were significant factors. For AUD-2, male gender (OR = 5.49; 95%CI: 1.50-20.07), being a BD (OR = 0.52; 95%CI: 0.30-0.92), and the depersonalization subscale score (OR = 1.05; 95%CI: 1.005-1.10) were associated. Conclusions: AUD is prevalent among public transportation drivers in Lima. Male gender and being a mototaxi driver seem to increase AUD risk, while depersonalization is linked to alcohol dependence severity.

  • Open Access

    Changes in loss to follow-up among elderly patients with schizophrenia during the COVID-19 pandemic: A study from a specialized center in Peru

    by Paulo Ruiz-Grosso, Luis Macedo-Orrego, Sonia Zevallos-Bustamante

    To estimate the survival function and identify risk factors for loss to follow-up (LTFU) among elderly patients with schizophrenia treated at the National Institute of Mental Health (INSM) in Peru. A retrospective cohort study was conducted using clinical records from 138 randomly selected patients diagnosed with schizophrenia. Eligible patients had attended at least one appointment between April 15, 2018, and April 15, 2022. Clinical and attendance data were recorded for each psychiatric appointment until the end of the follow-up period or LTFU. The survival function for LTFU was estimated, and associations with type of appointment (telemedicine vs. face-to-face) and period of first appointment (pre- vs. post-telemedicine implementation) were analyzed using Cox regression. The overall survival function at the end of the follow-up period was 47%. Patients whose treatment began at INSM after the implementation of telemedicine (TM) had a survival function of 49%, compared with 75% for those who initiated their treatment before TM. LTFU was significantly associated with initiating treatment in the Emergency Department (ED) rather than through outpatient care and with starting treatment post-COVID-19. Our findings indicate a higher rate of LTFU among patients who began treatment at INSM during the post COVID-19 period or through the Emergency Department. These results highlight the need for targeted interventions to address these risk factors and improve continuity of care for this vulnerable population.

  • Open Access

    Validation and Psychometric Properties of a Depression Scale for People with Tuberculosis in Lima, Peru

    by Paulo Ruiz-Grosso, Johann Vega-Dienstmaier, Cesar Ugarte-Gil

    Background Depression is a known risk factor for poor outcomes during tuberculosis (TB) treatment. Assessing depressive symptoms in TB patients is challenging due to overlap with symptoms of the disease and side effects of treatment, such as fatigue, sleep disturbance, and appetite changes. This study aimed to develop and validate a screening scale for major depressive episodes in patients undergoing TB treatment. Methods A cross-sectional validation study was conducted using 58 items drawn from previously validated Spanish-language depression scales. These items were administered to adults receiving TB treatment in Lima, Peru. Diagnosis of a major depressive episode was determined through a SCID-5 interview conducted by a psychiatrist. Items were selected sequentially based on individual area under the receiver operating characteristic curve (auROC), with the final selection made when no further gain in discrimination was observed. Internal consistency and diagnostic performance were assessed. Results Among 163 participants, an 8-item scale achieved an auROC of 95.9% (95% CI: 92– 99.9%), sensitivity of 87.2%, and specificity of 92.2% at a cutoff score ≥11. Internal consistency was good (Cronbach’s α and McDonald’s ω = 0.804). Items on anhedonia, energy, sleep, and appetite were excluded. Conclusion The validated 8-item scale showed strong discriminative accuracy and internal consistency for detecting major depressive episodes in TB patients.

  • Open Access

    Review of: "Prevalence, Patterns, and Correlates of Depression Among Drug-Susceptible Tuberculosis Patient Enrollees in Ogbomoso, Oyo State: A Cross-Sectional Study"

    by Paulo Ruiz-Grosso

    I would like to sincerely thank and congratulate the authors for highlighting the important role of mental health determinants during TB treatment. Overall, I found the manuscript well-written and of clear interest to the scientific community. I appr...

  • Open Access

    Association between tuberculosis and cocaine on negative outcomes of tuberculosis treatment: a systematic review and metaanalysis

    by Franco Carpio, Dora Torres, Carolina Salguero, Renzo Lindo, Paulo Ruiz-Grosso

    Tuberculosis (TB) remains a significant global health burden, with substance abuse being a common comorbidity. Cocaine-derived drugs, particularly crack and cocaine hydrochloride, have been associated with poor TB treatment outcomes. Objective: This systematic review aimed to synthesize the evidence on the relationship between crack or cocaine hydrochloride use and TB treatment outcomes. Materials and methods: A comprehensive search was conducted across multiple databases (PubMed, Ovid, EBSCOhost, Lilacs, and Google Scholar) using structured search terms. Eligible studies were included in a meta-analysis performed using STATA 16. Results: Five studies were included in the analysis. Overall, crack or cocaine use was associated with a higher risk of loss to follow-up or non-completion of TB treatment (OR = 2.73; 95% CI: 1.33-5.61). In the subgroup of individuals with active TB, this association was particularly strong for loss to follow-up (OR = 7.029; 95% CI: 2.66-18.57). However, no significant association was observed between crack or cocaine use and treatment non-completion in the latent TB subgroup (OR = 1.26; 95% CI: 0.77-2.05). Conclusions: Consumption of crack or cocaine is associated with adverse TB treatment outcomes, particularly loss to follow-up among individuals with active TB. These findings highlight the importance of addressing substance abuse as part of comprehensive TB control strategies.

  • Open Access

    Loss to follow-up of ambulatory patients in the transition to telemedicine in the COVID-19 pandemic at a reference center for mental health in Lima, Peru

    by Paulo Ruiz-Grosso, Abel Sagastegui, Sonia Zevallos-Bustamante

    Problem Statement During the COVID-19 pandemic, health care services were limited by the restrictive measures implemented. As an adaptation mechanism, telemedicine was introduced for ambulatory care at the Honorio Delgado Hideyo Noguchi National Institute of Mental Health (NIMH). This study aimed to estimate the survival function (SF) for loss to follow-up (LTFU) over two years before and after the onset of the COVID-19 pandemic, and its association with clinical and sociodemographic variables. Study Design A single-cohort study was conducted, following a random sample of adult ambulatory patients at NIHM from April 15, 2018, to April 15, 2022. Patients were followed until LTFU, referral to another institution, death, or the end of study. The main analysis involved estimating the SF for LTFU for the overall follow up period, as well as separately for the periods pre and post implementation of telemedicine. Also, risk factors hypotheses were tested using Cox’s regression. Results Data from 4887 visits of 356 patients were collected. A total of 118 (33.1%) presented LTFU, with SF of 53.9% during the overall four years of follow-up. After two years of follow-, those starting treatment at NIMH before the implementation of telemedicine had a higher SF (77.3 vs 63%). A higher hazard ratio (HR) for LTFU was found in the group that started care at NIMH after the implementation of telemedicine, compared to those who started previously (HR=2.53; 95% CI: 1.55-4.51). Additionally, receiving care in the anxiety disorders (HR=1.86; 95% CI: 1.03-3.33) and personality disorders programs (HR=1.81; 95% CI: 1.02-3.22) was associated with a higher risk of LTFU compared to the psychosis program. No significant difference was found in the risk of LTFU between telemedicine vs. face-to face attention. Conclusions A significant association was found between LTFU and starting treatment at NIMH after the onset of the COVID-19 pandemic and implementation of telemedicine. However, no evidence supports that this might be due to the practice of telemedicine. A different clinical profile of patients that started treatment at NIMH following the government implementation of changes to the public health system might explain these findings and should be studied. Significant Outcomes - A moderate association was found between starting treatment at NIMH and loss to follow up in the period after the implementation of telemedicine due to the onset of COVID-19. - This, however, does not seem to be related to the practice of telemedicine, but to changes in the characteristics of patients across pre and post COVID 19. Limitations - The reason for loss to follow up (death, return to a lower-level health service, improvement of symptoms, etc.), our main outcome variable, could not be determined using the clinical and administrative data available.